Skip to content
10-Q

Quarterly Report

IMMUNOVANT, INC. IMVT

0001764013-25-000149

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2026 · Nov 3, 2025 175.28M sh
Shares Diluted Q2 2026 · Sep 30, 2025 173.64M sh
Shares Diluted Q2 2026 · Sep 30, 2025 172.3M sh
Shares Diluted Q2 2026 · Sep 30, 2024 146.47M sh
Shares Diluted Q2 2026 · Sep 30, 2024 146.31M sh
Capex Q2 2026 · Sep 30, 2025 $0
Capex Q2 2026 · Sep 30, 2024 $378K
Operating Cash Flow Q2 2026 · Sep 30, 2025 −$219.93M
Operating Cash Flow Q2 2026 · Sep 30, 2024 −$164.85M
Cash And Equivalents Q2 2026 · Sep 30, 2025 $521.87M
Cash And Equivalents Q2 2026 · Mar 31, 2025 $713.97M
Stockholders Equity Q2 2026 · Sep 30, 2025 $519.71M
Stockholders Equity Q2 2026 · Jun 30, 2025 $608.54M
Stockholders Equity Q2 2026 · Mar 31, 2025 $707.45M
Stockholders Equity restated Q2 2026 · Sep 30, 2024 $449.05M
Stockholders Equity Q2 2026 · Jun 30, 2024 $544.66M
Stockholders Equity Q2 2026 · Mar 31, 2024 $617.76M
Current Liabilities Q2 2026 · Sep 30, 2025 $63.25M
Current Liabilities Q2 2026 · Mar 31, 2025 $68.78M
Total Liabilities Q2 2026 · Sep 30, 2025 $63.25M
Total Liabilities Q2 2026 · Mar 31, 2025 $68.78M
Current Assets Q2 2026 · Sep 30, 2025 $573.55M
Current Assets Q2 2026 · Mar 31, 2025 $767.76M
Total Assets Q2 2026 · Sep 30, 2025 $582.96M
Total Assets Q2 2026 · Mar 31, 2025 $776.22M
Eps Diluted Q2 2026 · Sep 30, 2025 −$0.73
Eps Diluted Q2 2026 · Sep 30, 2025 −$1.43
Eps Diluted Q2 2026 · Sep 30, 2024 −$0.74
Eps Diluted Q2 2026 · Sep 30, 2024 −$1.34
Eps Basic Q2 2026 · Sep 30, 2025 −$0.73
Eps Basic Q2 2026 · Sep 30, 2025 −$1.43
Eps Basic Q2 2026 · Sep 30, 2024 −$0.74
Eps Basic Q2 2026 · Sep 30, 2024 −$1.34
Sga Expense Q2 2026 · Sep 30, 2025 $17.51M
Sga Expense Q2 2026 · Sep 30, 2025 $43.54M
Sga Expense Q2 2026 · Sep 30, 2024 $18.47M
Sga Expense Q2 2026 · Sep 30, 2024 $37.28M
Net Income Q2 2026 · Sep 30, 2025 −$126.5M
Net Income Q2 2026 · Sep 30, 2025 −$247.12M
Net Income Q2 2026 · Jun 30, 2025 −$120.61M
Net Income Q2 2026 · Sep 30, 2024 −$109.12M
Net Income Q2 2026 · Sep 30, 2024 −$196.27M
Net Income Q2 2026 · Jun 30, 2024 −$87.15M